Breaking News

Argentina Dollar Bonds Due 2033 Drop for Second Day
Tweet TWEET

Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D

           Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D

  PR Newswire

  BANGALORE, February 15, 2013

BANGALORE, February 15, 2013 /PRNewswire/ --

Kemwell Biopharma Pvt. Ltd, a global pharmaceutical contract development and
manufacturing company, announced that it has appointed Dr. Ninad Deshpanday as
President of Research and Development.

Anurag Bagaria, Chairman and Managing Director of Kemwell said, "Dr.
Deshpanday brings a unique combination of leadership skills and technical
expertise in pharmaceutical development, as well as excellent business
development skills with a very strong network of customers in the US, Europe
and Asia. He will spearhead the R&D business for Kemwell as we continue to
grow the geographical footprint and strategically position Kemwell into a
leading Global Contract Services Provider."

Dr. Deshpanday has over 22 years' experience of diverse international
experience in the pharmaceutical industry (US + India). This includes
pharmaceutical development activities for NDAs, specialty drug delivery based
505(b)(2) products, including Oral and Transdermal, and complex Generic
products, with several F2Fs and PIVs. He also has rich experience in Technical
and Business Development

Prior to joining Kemwell, he was President of Pharmaceutical R&D at Lupin, in
Pune, India since Nov. 2007, with leadership responsibilities for
formulations, analytical, and BA/BE activities. Before joining Lupin, Dr.
Deshpanday was Vice President of Business Development at AAIPharma in RTP, NC,
with responsibilities for sales and marketing activities for their CM&C
functions; Vice President for Drug Product Development for Synta
Pharmaceuticals, with responsibilities for all CM&C activities; andTechnical
Business Director for the Pharmaceutics division of Cardinal Health. Dr.
Deshpanday earned his Doctorate in Pharmaceutics from the University of S.
Carolina in 1990, and has an M. Pharm. and B. Pharm. from LM College of
Pharmacy in Ahmedabad, India.

About Kemwell Biopharma Pvt. Ltd.

Kemwell Biopharma Pvt. Ltd, headquartered in Bangalore, India is a pure-play
global contract development and manufacturing company. The company
manufactures and develops pharmaceuticals for some of the world's top
pharmaceutical companies, including GlaxoSmithKline, Bayer, Novartis and
Pfizer. Kemwell is one of India's largest contract manufacturers of
pharmaceuticals with over 30 years' experience. The company employs more than
1000 employees worldwide and has seven production facilities, five in India
and two in Sweden. Kemwell is an approved pharmaceutical manufacturer in over
80 countries including the American, European, Japanese and Indian markets.
Read more about Kemwell on www.kemwellbiopharma.com .

Primary Media Contact: Karan Bagaria, karan.bagaria@kemwellpharma.com ,
91-80-39286200

Secondary Media Contact: Bhaskar Viswanathan,
bhaskar.viswanathan@kemwellpharma.com , 91-80-39286200

Contact: PRN